Koers CanaQuest Medical Corp Other OTC
Aandelen
CA01551X1087
Farmaceutische producten
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 1,49 mln. 1,38 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -2 mln. -1,85 mln. | Nettowinst (verlies) 2018 | -1 mln. -926K | EV/omzet 2017 | - |
Nettoschuld 2017 | 91,34K 84,57K | Nettoschuld 2018 | 154K 142K | EV/omzet 2018 | - |
K/w-verhouding 2017 |
-1,01
x | K/w-verhouding 2018 |
-1,17
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 43,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Ramsay
FOU | Founder | 64 | 07-10-08 |
Richard Rusiniak
FOU | Founder | 75 | 07-10-08 |
Ross Eastley
DFI | Director of Finance/CFO | 76 | 01-01-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Rusiniak
FOU | Founder | 75 | 07-10-08 |
Paul Ramsay
FOU | Founder | 64 | 07-10-08 |
W. McDonald
BRD | Director/Board Member | 58 | 28-08-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,50% | 6,2 mld. | |
-22,89% | 4,1 mld. | |
+9,36% | 3,41 mld. | |
-19,39% | 2,83 mld. | |
-11,05% | 2,29 mld. | |
+45,24% | 1,93 mld. | |
-7,51% | 1,52 mld. | |
+46,81% | 1,51 mld. | |
-18,04% | 1,49 mld. |